Ian Reed

Pfizer (NYSE: PFE) reported second quarter earnings that beat analyst estimates. However, with the loss of Lipitor exclusivity and Viagra next to go, the future remains challenging. Pfizer's net income increased in the quarter, jumping 25 percent to $3.25 billion from $2.61 billion a year ago....